- Report
- April 2020
- 182 Pages
Global
From €3803EUR$4,000USD£3,195GBP
- Report
- October 2024
- 80 Pages
Vietnam
From €3422EUR$3,600USD£2,875GBP
- Report
- January 2024
- 155 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2024
- 199 Pages
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- January 2025
- 73 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- July 2024
- 91 Pages
From €3280EUR$3,450USD£2,755GBP
- Report
- October 2023
- 189 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- November 2023
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- February 2024
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2022
- 105 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- March 2023
- 112 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- December 2023
- 126 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- August 2022
- 100 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- May 2022
- 40 Pages
Argentina
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2022
- 40 Pages
Poland
From €1426EUR$1,500USD£1,198GBP
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2022
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2022
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP

The Human Vaccine market is a segment of the larger Vaccine industry, which focuses on the development and distribution of vaccines to protect humans from infectious diseases. Vaccines are typically administered through injections, although some may be administered orally or nasally. Vaccines are designed to stimulate the body's immune system to recognize and fight off a particular disease. Vaccines are typically developed through a combination of laboratory research, clinical trials, and regulatory approval.
The Human Vaccine market is highly competitive, with a number of large pharmaceutical companies and biotechnology firms competing for market share. Companies in the market are focused on developing new vaccines, as well as improving existing vaccines. They are also involved in the production, distribution, and marketing of vaccines.
Some of the major companies in the Human Vaccine market include Merck & Co., GlaxoSmithKline, Pfizer, Sanofi, Johnson & Johnson, and Novartis. Show Less Read more